徐俊杰 Junjie Xu

浙江大学医学院附属邵逸夫医院：长期专注于肝癌精准诊疗与耐药机制的转化研究，在 Sig Transduct Target Ther、Molecular Cancer 等权威期刊发表多篇高水平论文，具备临床与基础研究并重的优势。

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine: Has long focused on translational research in precision diagnosis and treatment of liver cancer and drug resistance mechanisms. Has published multiple high-level papers in authoritative journals such as Signal Transduction and Targeted Therapy and Molecular Cancer, with strengths in both clinical and basic research.